Media Archive

Cellular Bioengineering Snags the Nation’s Top R&D Honors

As published in 2005 October, Hawaii Business Magazine by Jacy L. Youn:

The R&D 100 awards. Dubbed “The Oscars of Invention,” they are the nation’s top honors in research and development, presented annually by R&D Magazine to the companies and organizations behind the best, brightest innovations in America. With former award-winning inventions ranging from the fax machine to the artificial kidney, making the list is no small feat. A fact that isn’t lost for a second on Hank Wuh, founder and chief executive officer of Honolulu-based Cellular Bioengineering Inc. (CBI), which this year has been selected an R&D 100 Award recipient, for its development of the Neural Matrix Chip. “It’s an honor. It truly is an honor,” says Wuh. “They only pick 100 companies each year, and we’re very proud to be one of them.” …read more.

Cellular Bioengineering Wins Major R&D Award

As published in 2005 September Pacific Business News by Clynton Namuo:

Cellular Bioengineering Inc. has received one of R&D magazine’s R&D 100 Awards, recognizing the world’s best innovations in technology in the past year.

The company won the award for its neural matrix chip that allows for the growth of nerve cells in specific patterns on a microchip.

Founder and CEO Hank Wuh is hoping the R&D award will propel his Honolulu-based company into the big leagues of technology companies and generate worldwide attention from corporate and institutional clients….read more.

A Biotech Firm with its Eyes on the Prize

As published in 2005 February, Hawaii Business Magazine by Jacy L. Youn:

Hank Wuh may have successfully avoided the limelight for the past year and a half, ever since he formed the Moiliili-based biotech firm, Cellular Bioengineering Inc. (CBI) in mid-2003. But if things continue to progress as nicely as they have for Wuh and CBI, they may soon be as ubiquitous as David Watumull and Hawaii Biotech are in the world of, well, Hawaii biotech.

Despite CBI’s decidedly low-tech location (its lab facilities are located off of Young Street near McCully), the company’s 12 employees are working on some very high-tech life science products. Its primary focus is regenerative medicine, or the bioengineering of replacement parts for aging and diseased tissues and organs. CBI’s most advanced technology, which involves the growth of cornea (the outermost layer of an eyeball) cells, has potentially a multi-billion dollar market. “Corneal transplants are the most frequently performed human transplant procedure,” says Wuh. “But there are still about 10 million people worldwide who are blind from corneal-associated diseases because there aren’t enough donors. Our ultimate goal is to eliminate the need for donors entirely.” …read more

A Potential Billion Dollar Company

As published in 2005 February, Pacific Business News, by Terrence Sing:

A new Hawaii company hopes to make the blind see.
Cellular Bioengineering Inc., a biotech startup focused on regenerative medicine, has applied for patents on its proprietary bioengineering of replacement parts for aging, diseased or damaged tissues and organs.

The work the company is doing at its nondescript laboratory in Moiliili has the potential to revolutionize the way organs are replaced and create a life-sciences powerhouse in Honolulu.

In many ways, Cellular Bioengineering is a nearly perfect model for those promoting Hawaii’s economic diversification. The company could develop its technology anywhere, but chose Hawaii not only because of its proximity to Asian markets but also because half of its employees are kamaaina who received advanced degrees and came home from the Mainland.

“This is a potential billion-dollar annual revenue company,” …

Read more here.

Radio Interview in 2005 December

Dr. Hank Wuh has a plan to help millions of blind people to see. Cellular Bioengineering, Inc (CBI) has developed technology to produce corneas to be used in eye transplants. This has been talked about as a multi billion dollar venture with serious social benefit. Dr. Wuh left a promising surgery practice to become a full time inventor and entrepreneur.

Dr. Wuh invented medical devices as a resident at the Stanford University Hospital. He now is an inventor, CEO and investor in the life science field. Hear Dr. Wuh’s unique view of business and how a global mission is the new paradigm.

Some questions asked:
Welcome Hank, can you tell us about the Cellular Bioengineering Inc and what they do?
Does Cellular Bioengineering Inc have a stated business strategy or a “mission statement”?
What’s the story behind Cellular Bioengineering?
What is your role in the company?
Where do you do your science?
Did you ever practice medicine?
How did you become interested in this kind of study?
Congratulations on the award from R&D magazine. The R&D 100 Awards, recognizes the world’s best innovations in technology in the past year. How has the award helped you and your company to further your studies?
How are you able to fund your studies?
What are some of the interesting projects you are working on now?
How do you manage your time?
What do you do to support the community?
What was your experience with venture capitalists?
What do entrepreneurs need to do to raise venture capital?

Listen to the whole interview here.